Literature DB >> 33183324

Hemostatic effect of tourniquet combined with tranexamic acid in total knee arthroplasty: a network meta-analysis.

Yimin Zhang1, Bao Lang2, Guifeng Zhao3, Fengming Wang4.   

Abstract

BACKGROUND: There are various techniques to reduce blood loss in total knee arthroplasty (TKA), including the use of a tourniquet and tranexamic acid (TXA). In this study, we studied the combined effect of TXA with a tourniquet on blood loss in the setting of primary TKA.
METHODS: Randomized controlled trials (RCTs) of nine treatment methods were included (placebo, intravenous [i.v.] TXA, topical TXA, i.v.-combined topical TXA, oral TXA, placebo + tourniquet, i.v. TXA +tourniquet, topical TXA + tourniquet, and i.v.-combined topical TXA + tourniquet). The patients were divided into eight groups according to the different treatment strategies, with 30 cases per group. The differences in the total blood volume, the number of patients transfused, the hemoglobin before and after the operation, and complications after the operation were compared.
RESULTS: Totally 15 RCTs meeting our inclusion criteria were collected in this study. Compared with the placebo + tourniquet group, the i.v. TXA + tourniquet group displayed lower hemoglobin reduction value, pulmonary embolism (PE) incidence, total blood loss, and blood transfusion risk; the topical TXA + tourniquet group showed reduced PE incidence, total blood loss, and blood transfusion risk, and the i.v.-combined topical TXA and i.v.-combined topical TXA + tourniquet groups showed decreased total blood loss and lower blood transfusion risk. Retrospective clinical study results also demonstrated that the efficacy of i.v.-combined topical TXA was the best.
CONCLUSIONS: Our meta-analysis indicates that i.v.-combined topical TXA provides a low total blood loss without increasing the blood transfusion risk in patients undergoing total knee replacement surgery.

Entities:  

Keywords:  Hemostasis; Randomized controlled trial; Total knee replacement; Tourniquets; Tranexamic acid

Mesh:

Substances:

Year:  2020        PMID: 33183324      PMCID: PMC7663901          DOI: 10.1186/s13018-020-02010-z

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  35 in total

1.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.

Authors:  Georgia Salanti; A E Ades; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2010-08-05       Impact factor: 6.437

2.  The Effects of Tourniquet Application in Total Knee Arthroplasty on the Recovery of Thigh Muscle Strength and Clinical Outcomes.

Authors:  Omer Ayik; Mehmet Demirel; Fevzi Birisik; Ali Ersen; Halil I Balci; Turker Sahinkaya; Sefa Giray Batibay; Irfan Ozturk
Journal:  J Knee Surg       Date:  2020-02-19       Impact factor: 2.757

Review 3.  Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.

Authors:  G-Q Zhu; K-Q Shi; S Huang; L-R Wang; Y-Q Lin; G-Q Huang; Y-P Chen; M Braddock; M-H Zheng
Journal:  Aliment Pharmacol Ther       Date:  2015-02-13       Impact factor: 8.171

4.  Does Tourniquet Use in TKA Affect Recovery of Lower Extremity Strength and Function? A Randomized Trial.

Authors:  Douglas A Dennis; Andrew J Kittelson; Charlie C Yang; Todd M Miner; Raymond H Kim; Jennifer E Stevens-Lapsley
Journal:  Clin Orthop Relat Res       Date:  2016-01       Impact factor: 4.176

5.  The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.

Authors:  Deniz Cankaya; Uygar Dasar; Ahmet Burak Satilmis; Serdar Hakan Basaran; Mustafa Akkaya; Murat Bozkurt
Journal:  J Orthop Surg (Hong Kong)       Date:  2017-01       Impact factor: 1.118

6.  The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial.

Authors:  Yang Yang; Yong-Ming Lv; Pei-Jian Ding; Jia Li; Zhang Ying-Ze
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-05-10

7.  The Assessment of Blood Loss During Total Knee Arthroplasty When Comparing Intravenous vs Intracapsular Administration of Tranexamic Acid.

Authors:  Jedediah H May; Geoffrey R Rieser; Chad G Williams; Ronald J Markert; Ryan D Bauman; Matthew W Lawless
Journal:  J Arthroplasty       Date:  2016-04-30       Impact factor: 4.757

8.  The comparative efficacy and safety of topical and intravenous tranexamic acid for reducing perioperative blood loss in Total knee arthroplasty- A randomized controlled non-inferiority trial.

Authors:  Jefferson George; Krishna Kiran Eachempati; Koushik Narayan Subramanyam; A V Gurava Reddy
Journal:  Knee       Date:  2018-01-17       Impact factor: 2.199

Review 9.  Is combined topical with intravenous tranexamic acid superior than topical, intravenous tranexamic acid alone and control groups for blood loss controlling after total knee arthroplasty: A meta-analysis.

Authors:  Chunmei Lin; Yingmei Qi; Li Jie; Hong-Biao Li; Xi-Cheng Zhao; Lei Qin; Xin-Qiang Jiang; Zhen-Hua Zhang; Liping Ma
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

10.  Assessing the quality of randomized controlled urological trials conducted by korean medical institutions.

Authors:  Jae Hoon Chung; Seung Wook Lee
Journal:  Korean J Urol       Date:  2013-05-14
View more
  2 in total

1.  The effects of a new protocol on blood loss in total knee arthroplasty.

Authors:  Giuseppe Maccagnano; Vito Pesce; Giovanni Noia; Michele Coviello; Giovanni Vicenti; Raffaele Vitiello; Antonio Ziranu; Antonio Spinarelli; Biagio Moretti
Journal:  Orthop Rev (Pavia)       Date:  2022-08-25

2.  Comparison of the Utilization of Tranexamic Acid and Tourniquet Use in Total Knee Arthroplasty: A Retrospective Case Series.

Authors:  Promil Kukreja; Brittany M Johnson; Corey Traylor; Kevin J O'Keefe; Sameer Naranje; Jason McKeown; Christopher A Paul; Brooke Bell
Journal:  Cureus       Date:  2022-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.